Glucagonlike Peptide-1 Receptor Agonists and Asthma Risk in Adolescents With Obesity

This cohort study investigates the association between glucagonlike peptide-1 receptor agonist use and the risk of acute asthma exacerbations among adolescents with overweight or obesity and asthma.

Corresponding Authors: Lin-Shien Fu, MD, Taichung Veterans General Hospital, 1650 Taiwan Blvd Sect 4, Taichung, Taiwan (linshienfu@gmail.com); Tim C. C. Lin, PhD, National Chung-Hsing University, 145 Xingda Rd, South Dist, Taichung, Taiwan (chichenlin1@gmail.com).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.